Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 30 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

7%

2 trials in Phase 3/4

Results Transparency

18%

2 of 11 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

19Total
Not Applicable (11)
P 1 (2)
P 2 (4)
P 4 (2)

Trial Status

Completed11
Unknown9
Recruiting5
Not Yet Recruiting2
Withdrawn2
Suspended1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (30)

Showing 20 of 20 trials
NCT07140484Phase 4RecruitingPrimary

Sotatercept in Pulmonary Arterial Hypertension

NCT03152773Not ApplicableSuspendedPrimary

Heart Catheterization Using Magnetic Resonance Imaging (MRI) Fluoroscopy and Passive Guidewires

NCT06035861Not ApplicableNot Yet RecruitingPrimary

Endothelial Cell Activation and Total Pulmonary Resistance in PAH

NCT03138863Not ApplicableRecruiting

Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia (FETO)

NCT04610788Completed

Cardiac Assessment by PV Loop in IPAH and Scleroderma PAH

NCT02966665Phase 1Recruiting

: Vascular Function in Health and Disease

NCT03617458Phase 2CompletedPrimary

Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension

NCT01581086CompletedPrimary

Vascular Subphenotypes of Lung Disease in HIV & COPD

NCT06544148RecruitingPrimary

Non-Invasive Measurements of Changes in Pulmonary Artery Pressure in Intensive Care Unit Patients Using Electrical Impedance Tomography - A Feasibility Study

NCT06429579Not ApplicableRecruitingPrimary

Potts-shunt for the Treatment of Pediatric Patients With Severe Pulmonary Hypertension

NCT06258850Phase 4Not Yet RecruitingPrimary

REstoration of VItamin D in Pulmonary Arterial Hypertension

NCT06122922Phase 2WithdrawnPrimary

Xenon MRI in Stable Pulmonary Hypertension (Jupiter AUGEAN)

NCT04456998Phase 2CompletedPrimary

GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)

NCT06084559Not ApplicableUnknown

HA Residents With PVD, Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) With and Without Supplemental Oxygen Therapy (SOT)

NCT06072417Not ApplicableUnknown

HA Residents With PVD, SDB Assessed at HA (2840m) vs LA (Sea Level)

NCT06003244Not ApplicableUnknown

High Altitude (HA) Residents With Pulmonary Vascular Diseases (PVD), 6 Minute Walk Distance (6MWD) Assessed at 2840m (HA) With and Without Supplemental Oxygen Therapy (SOT)

NCT05996302Not ApplicableUnknown

HA Residents With PVD, 6MWD Assessed at HA (2840m) vs LA (Sea Level)

NCT05421949CompletedPrimary

Assessing the Repeatability of NT-proBNP Testing Using Laboratory and Point of Care Testing in PAH

NCT03979482CompletedPrimary

Skeletal Muscle Mitochondrial Abnormalities and the Metabolic Syndrome in PAH

NCT05056532CompletedPrimary

Evaluation of Respiratory Muscle in Patient With Pulmonary Arterial Hypertension

Scroll to load more

Research Network

Activity Timeline